Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.
2.

Predictor of event-free survival in patients with myocardial infarction.

Henareh L, Berglund M.

Acute Card Care. 2012 Sep;14(3):105-9. doi: 10.3109/17482941.2012.712142.

PMID:
22934967
3.

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively.

Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P, Swiatkowski A, Sredniawa B, Kowalski O, Polonski L, Strojek K, Kalarus Z.

Cardiovasc Diabetol. 2012 Jun 28;11:78. doi: 10.1186/1475-2840-11-78.

4.

Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.

Wang CC, Chen WL, Kao TW, Chang YW, Loh CH, Chou CC.

Clin Ther. 2011 Dec;33(12):1904-13. doi: 10.1016/j.clinthera.2011.10.025. Erratum in: Clin Ther. 2012 Feb;34(2):508. Chou, Chih-Chieh [corrected to Chou, Chin-Chieh].

PMID:
22118894
5.

Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).

White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S; LIPID Study Investigators..

J Am Coll Cardiol. 2014 Feb 4;63(4):345-54. doi: 10.1016/j.jacc.2013.08.1643.

6.

The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease.

Johnson J, Manouras A, Bergholm F, Brodin LÅ, Agewall S, Henareh L.

Clin Physiol Funct Imaging. 2014 Sep;34(5):389-96. doi: 10.1111/cpf.12110.

PMID:
24438358
7.

Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.

Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, Jung H, Desai D, Bosch J, Yusuf S, Gerstein HC; EpiDREAM Investigators..

Eur J Prev Cardiol. 2012 Aug;19(4):755-64. doi: 10.1177/1741826711409327.

PMID:
21551215
8.

Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.

Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, Gudbjörnsdóttir S; Swedish National Diabetes Register..

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):506-12. doi: 10.1097/HJR.0b013e32832ccc50.

PMID:
19561510
9.

Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction.

Kaplan RC, Heckbert SR, Furberg CD, Psaty BM.

J Clin Epidemiol. 2002 Jul;55(7):654-64.

PMID:
12160913
10.

Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H.

Cardiovasc Diabetol. 2006 Jul 17;5:15.

11.

Admission with metabolic disorder is a useful predictor of the 1-year prognosis for patients with unstable angina, but not for patients with acute myocardial infarction: east-Osaka acute coronary syndrome registry.

Hoshida S, Teragaki M, Lim YJ, Mishima M, Nakajima O, Kijima Y, Yoshimaru K, Tsuchihashi M, Morita Y, Iwasaka T; EACS investigators..

Coron Artery Dis. 2011;22(6):416-20. doi: 10.1097/MCA.0b013e3283472a87.

PMID:
21555939
12.

Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.

Engström G, Hedblad B, Janzon L, Lindgärde F.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):392-7.

PMID:
17568238
13.

Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.

Bengtsson C, Ohman ML, Nived O, Rantapää Dahlqvist S.

Lupus. 2012 Apr;21(4):452-9. doi: 10.1177/0961203311425524.

PMID:
22065097
14.

Insulin resistance predicts the risk for recurrent coronary events in post-infarction patients.

Szepietowska B, McNitt S, Kutyifa V, Ryan D, Corsetti J, Sparks C, Moss AJ, Zareba W.

Cardiol J. 2015;22(5):519-26. doi: 10.5603/CJ.a2015.0014.

PMID:
25733322
15.

Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.

Dunder K, Lind L, Lagerqvist B, Zethelius B, Vessby B, Lithell H.

Am Heart J. 2004 Mar;147(3):502-8.

PMID:
14999201
16.

Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range.

Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS, Laatikainen T, Tuomilehto J, Pyörälä K, Qiao Q; DECODE Finnish and Swedish Study Investigators..

Cardiovasc Diabetol. 2012 Jun 25;11:76.

17.

Value of oral glucose tolerance test in the acute phase of myocardial infarction.

Bronisz A, Kozinski M, Magielski P, Fabiszak T, Gierach J, Swiatkiewicz I, Sukiennik A, Kubica A, Bronisz M, Grabczewska Z, Sinkiewicz A, Junik R, Kubica J.

Cardiovasc Diabetol. 2011 Mar 11;10:21. doi: 10.1186/1475-2840-10-21.

18.

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.

Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE.

Cardiovasc Diabetol. 2013 Aug 30;12:126. doi: 10.1186/1475-2840-12-126.

19.

Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registry.

Venketasubramanian N, Röther J, Bhatt DL, Pasquet B, Mas JL, Alberts MJ, Hill MD, Aichner F, Steg PG; REACH Investigators..

Cerebrovasc Dis. 2011;32(3):254-60. doi: 10.1159/000328650.

PMID:
21876353
20.

The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.

Chan CY, Li R, Chan JY, Zhang Q, Chan CP, Dong M, Yan BP, Lam YY, Yu CM.

Clin Cardiol. 2011 Aug;34(8):507-12. doi: 10.1002/clc.20915.

Supplemental Content

Support Center